As you know, it's an area of strength in Canada. Canada has some of the top researchers in the world in the field of neuroscience. We have international repute in that area, and CIHR spends a significant amount of money on that. We're talking about ongoing yearly spending of over $120 million, a commitment for 2010-11, and an ongoing commitment of roughly $300 million, so it's very significant investment in top research.
In addition to that, CIHR has made Alzheimer's disease and related dementias one of its top priorities. We believe we have the leadership in Canada to lead an international strategy on Alzheimer's research. We've already signed MOUs with France, the U.K., and Germany. We're currently negotiating with the United States and China to lead a truly international effort in that area so as not to duplicate efforts and to leverage international funds to go further faster in our fight against Alzheimer's.